Gaku Izumi

Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a randomised controlled, open-label, blinded-endpoints, phase 3 trial

Hiroyuki Suzuki, Masaru Terai, Shigeto Fuse et al. · The Lancet · 2019 · 208 citations

Medicine, Cardiology, Immunology +11

Risk factors and serological markers of liver cirrhosis after Fontan procedure

Mikiko Shimizu, Kenji Miyamoto, Yunosuke Nishihara et al. · Heart and Vessels · 2015 · 40 citations

Medicine, Cardiology, Surgery +16

Advanced pathological study for definite diagnosis of mitochondrial cardiomyopathy

Atsuhito Takeda, Kei Murayama, Yasushi Okazaki et al. · Journal of Clinical Pathology · 2020 · 18 citations

Medicine, Cardiology, Pathology +13

Risk factors for hospitalisation due to respiratory syncytial virus infection in children receiving prophylactic palivizumab

Ayako Nagai, Hiroki Sato, Itsumi Sato et al. · European Journal of Pediatrics · 2021 · 18 citations

Medicine, Infectious Diseases, Pediatrics +16

Barth syndrome diagnosed in the subclinical stage of heart failure based on the presence of lipid storage myopathy and isolated noncompaction of the ventricular myocardium

Atsuhito Takeda, Akira Sudo, Masafumi Yamada et al. · European Journal of Pediatrics · 2011 · 17 citations

Medicine, Cardiology, Clinical Cardiology +6